ACTINIUM PHARMACEUTICALS INC (ATNM) Stock Earnings & Estimates
NYSEARCA:ATNM - US00507W2061 - Common Stock
1.58 USD
-0.11 (-6.51%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.144M | 1.03M -9.97% | 81K -92.14% | 193.117K -100.00% | 47.544M | 37.534M -21.05% | 130.02M 246.41% | 163.49M 25.74% | 232.39M 42.14% | 392.91M 69.07% | |||
| EBITDA YoY % growth | -24.44M -11.36% | -33.405M -36.68% | -51.13M -53.06% | -49.572M 19.21% | -43.86M -6.17% | -55.794M -27.21% | -63.75M -14.26% | -58.242M 8.64% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.964M -11.48% | -34.104M -36.61% | -51.92M -52.24% | -47.784M 18.87% | -45.735M -8.58% | -51.343M -12.26% | -47.548M 7.39% | -29.421M 38.12% | 45.34M 254.11% | 59.143M 30.44% | 105.53M 78.43% | 205.56M 94.79% | |
| Operating Margin | -2,182.17% | -3,311.07% | -64,098.77% | -24,743.57% | N/A | N/A | -100.01% | -78.38% | 34.87% | 36.18% | 45.41% | 52.32% | |
| EPS YoY % growth | -1.20 41.18% | -1.37 -14.17% | -1.84 -34.31% | -1.43 30.98% | -1.36 -7.22% | -1.03 24.34% | -1.08 -4.46% | -0.90 15.95% | -0.22 75.19% | 0.29 229.55% | 0.96 231.58% | 1.63 69.31% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 -0.62% | -0.24 -16.57% | -0.58 -14.00% | -0.54 -145.73% | -0.49 -31.51% |
| Revenue Q2Q % growth | 8.429M | 10.145M | 11.861M | ||
| EBITDA Q2Q % growth | -8.466M 29.41% | -9.69M -44.76% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.894M 13.55% | -9.003M -19.95% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.22 42.11% | -0.36 | 0.14 | 38.38% |
| Q1 2025 Q2Q % growth | -0.51 -64.52% | -0.28 | -0.23 | -80.18% |
| Q4 2024 Q2Q % growth | -0.21 38.24% | -0.38 | 0.17 | 44.95% |
| Q3 2024 Q2Q % growth | -0.37 24.49% | -0.34 | -0.03 | -7.96% |
| Q2 2024 Q2Q % growth | -0.38 34.48% | -0.41 | 0.03 | 8.01% |
| Q1 2024 Q2Q % growth | -0.31 27.91% | -0.53 | 0.22 | 41.55% |
| Q4 2023 Q2Q % growth | -0.34 20.93% | -0.55 | 0.21 | 38.27% |
| Q3 2023 Q2Q % growth | -0.49 -28.95% | -0.54 | 0.05 | 9.64% |
| Q2 2023 Q2Q % growth | -0.58 -75.76% | -0.49 | -0.09 | -18.46% |
| Q1 2023 Q2Q % growth | -0.43 -86.96% | -0.43 | 0.00 | 0.42% |
| Q4 2022 Q2Q % growth | -0.43 -19.44% | -0.36 | -0.07 | -18.75% |
| Q3 2022 Q2Q % growth | -0.38 -26.67% | -0.31 | -0.07 | -22.15% |
| Q2 2022 Q2Q % growth | -0.33 -32.00% | 0.52 | -0.85 | -164.07% |
| Q1 2022 Q2Q % growth | -0.23 20.69% | -0.32 | 0.09 | 28.42% |
| Q4 2021 Q2Q % growth | -0.36 2.70% | -0.31 | -0.05 | -15.72% |
| Q3 2021 Q2Q % growth | -0.30 16.67% | -0.28 | -0.02 | -5.80% |
| Q2 2021 Q2Q % growth | -0.25 39.02% | -0.30 | 0.05 | 17.61% |
| Q1 2021 Q2Q % growth | -0.29 67.78% | -0.30 | 0.01 | 3.07% |
| Q4 2020 Q2Q % growth | -0.37 58.89% | -0.38 | 0.01 | 1.96% |
| Q3 2020 Q2Q % growth | -0.36 70.00% | -0.45 | 0.09 | 20.24% |
| Q2 2020 Q2Q % growth | -0.41 54.44% | -0.41 | 0.00 | -0.52% |
| Q1 2020 Q2Q % growth | -0.90 40.00% | -0.71 | -0.19 | -26.07% |
| Q4 2019 Q2Q % growth | -0.90 | -1.22 | 0.32 | 26.47% |
| Q3 2019 Q2Q % growth | -1.20 | -1.12 | -0.08 | -6.94% |
| Q2 2019 Q2Q % growth | -0.90 | -1.22 | 0.32 | 26.47% |
| Q1 2019 Q2Q % growth | -1.50 | -1.73 | 0.23 | 13.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | 586.5K | -586.5K | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | 1.055M | -1.055M | -100.00% |
| Q3 2022 Q2Q % growth | 45K -80.69% | 500.647K | -455.647K | -91.01% |
| Q2 2022 Q2Q % growth | 45K -83.08% | 17.85M | -17.805M | -99.75% |
| Q1 2022 Q2Q % growth | 940K 51.13% | 940K | % | |
| Q4 2021 Q2Q % growth | 23K | 81.6K | -58.6K | -71.81% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.39% | 12.05% | -15.75% | -15.75% |
| Revenue | N/A | -100% | N/A | N/A |